Vascular Dementia 2017_Brochure

http://vasculardementia.conferenceseries.com/

Vascular Dementia 2017conferenceseries.com

Conference Secretariat2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA

Ph: +1-650-268-9744, Fax: +1-650-618-1414, Toll free: +1-800-216-6499Email: [email protected]

Brochure

Vascular DementiaAmsterdam, Netherlands February 27- March 01, 2017

6th International Conference on



Vascular Dementia 2017 welcomes you to attend the 6th International Conference on Vascular Dementia which is going to be held in Amsterdam, Netherlands during February 27- March 01, 2017.

We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Vascular Dementia.

Vascular Dementia 2017 anticipates more than 500 participants around the globe with thought provoking Keynote lectures, Oral Presentations and Poster Presentations. The attending delegates include Editorial Board Members of related Conference Series LLC Journals.

This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

The intending participants can confirm their participation by registering for the conference along with your colleagues.

The main theme of the conference is “Exploring the challenges concerning excellence in dementia research and care”. Avail the delegate early bird offer.

Regards,

Vascular Dementia 2017 Operating Committee

• Dementia• Causes and Prevention• Vascular Dementia• Ageing and Dementia• Advances in Dementia Test• Dementia Stages• Dementia Care Management• Vascular Dementia Nursing• Advanced Drug for Dementia• Potential Future Interventions• Neuro-entrepreneurship: Vascular Dementia• Animal Models and Translational Medicine

Conference Highlights

Invitation



The International Conference on Psychology, Autism and Alzheimer’s disease, organized by OMICS Group International was successfully held at Hilton San Antonio Airport, TX, USA during September 30-October 01, 2013.

OMICS Group is grateful to Dr. Andrew V. Schally, Nobel Prize in Medicine 1977, for his time and dedication as Honourable Organizing Committee Member, for his exceptional support towards PsychoAAD 2013.

The conference was organized with the theme “Global Perspectives and Current Trends in Psychology”. The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 20 different countries ultimately driving the event into the path of success.

The highlights of the conference were its educative and effectual keynote lectures by: Joseph M. Rifkind, National Institute of Aging, USA; Jaykumar Rajdas, Stanford University, USA; H. Craig Heller, Stanford University, USA; George Perry, University of Texas at San Antonio, USA; Ronald J. Killiany, Boston University, USA; Mitchell Clionsky, ClionskyNeuro Systems, USA; Kalyani Gopal, American Psychological Association, USA

Our special gratitude to our Collaborators Autism Community Network & Lebanese Psychological Association and Media Partners APPAC, Greece; Med tube, USA; ABP, Brazil; International Early Psychosis Association, Australia; Alzheimer’s Europe and Institute for forensic Criminology, Italy.

Past Conference Report-2013



The 2nd International Conference on Alzheimer’s disease and Dementia was organized by OMICS Group Inc., during September 23-25, 2014 at Valencia Convention Centre, Spain.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 35 countries, who have driven this event into the path of success.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers: Eric G. Tangalos, Mayo Clinic, USA; Sanjay Asthana, University of Wisconsin, USA; Howard Rowley, University of Wisconsin, USA; Toru Itakura, Wakayama Medical University, Japan; Alan Palmer, Cerebroscience Ltd, UK; Barbara C. Fisher, United Psychological Services, USA; Nigel Hooper, University of Manchester, UK; Federico Licastro, University of Bologna, Italy

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Dementia-2014. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Alzheimer’s Disease and Parkinsonismas a special issue. Basing on the conference theme, “Advanced Diagnostic & Therapeutic Approaches Towards Dementia” speakers recommended organizing the conference in the field of Alzheimer’s Disease and Dementia also in the next year.

Past Conference Report-2014



Past Conference Report-2015In the presence of inter professional researchers and practitioners involved in the development of high

quality education in all aspects of Alzheimer’s disease and Dementia, OMICS 3rd International Conference on Alzheimer’s Disease & Dementia was held during August 31-September 02, 2015 in Toronto, Canada.

OMICS International played host to a diverse panel of key members of the Neurology community from research lab, industry, academia and financial investment practices, discussing the future of Alzheimer’s and Dementia. This event was really aimed for examining where the real Alzheimer’s disease and Dementia specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Neurology.

Focusing on Alzheimer’s disease, Dementia, Neurological changes in brain, Alzheimer’s disease Imaging, Disease Mechanisms, Geriatrics and Cognitive Disorder, Pathophysiology, Brain trauma, Care practice and Awareness, Current Research in Dementia and Alzheimer’s Disease as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Dementia-2015 Organizing Committee would like to thank the Moderator of the conference Catherine Braxton, Generations Senior Care Consulting, USA, who contributed a lot for the smooth functioning of this event.

We are also thank full to all the speakers who made this event a grand success, our special thanks to

Barbara C Fisher, United Psychological Services, USA

Guosongliu, Neurocentria, Inc., USA

Tohru Hasegawa, Saga Woman Junior College, Japan

Claude M Wischik, TauRx Therapeutics, UK

Zhicheng Xiao, Monash University, Australia

Helen Chenery, Bond University, Australia

EefHogervorst, Loughborough University, UK

Linda Levine Madori, St. Thomas Aquinas College, USA

Jens Wiltfang, Georg August University Gottingen, Germany



So as continuation of Dementia 2015, we would like to heartily invite you to our upcoming 4th International Conference on Vascular Dementia scheduled at Valencia, Spain during June 30 – July 02, 2016.

The conference is organized with the theme “Integrating Recent Discoveries and Interpreting Vascular Dementia Research for Better Health”

The aim of the Conference Vascular Dementia 2016 is to provide a platform for academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

In addition to inspire and educate practitioners about appropriate treatment approaches for all types of Vascular Dementia and to encounter them in finding creative ways to identify, diagnose, understand and treat patients with all types of Vascular dementia with individualized focus and intention.

Vascular Dementia 2016 will be a platform where you will be sure to have a meaningful experience with scholars from around the world.

We look forward to see your benign presence with active contribution and support to make this event successful once more.

The highlights of the meeting were the eponymous lectures, delivered by Barbara C Fisher from United Psychological Services, USA, Claude M Wischik from TauRx Therapeutics, UK, Guosongliufrom Neurocentria, Inc., USA, Zhicheng Xiao from Monash University, Australia, Tohru Hasegawa fromSaga Woman Junior College, Japan, Helen Chenery from Bond University, Australia.

The entire above mentioned keynote speakers gave their energetic and fruitful contributions at 3rd International Conference on Alzheimer’s Disease & Dementia. The session chairs/Co chairs have proved their position and contributed a lot for the smooth functioning of the event.

All accepted abstracts have been indexed in the OMICS Group Journals as a special issue. OMICS Group felicitated all the Organizing Committee Members who enthusiastically participated in the conference and made this meeting a huge success.



Past Conference Report-2016Vascular Dementia 2016

The 4th International conference on Vascular Dementia (Vascular Dementia -2016) hosted by Conference Series LLC took place at Valencia, Spain during June 30th – July 2nd, 2016.

Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of Conference Series LLC Journals as well as from eminent scientists, talented researchers and young student community.

Researchers and students who attended from different parts of the world has made the conference one of the most successful and productive events in 2016 from Conference Series LLC.

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations highlighting the theme “Integrating Recent Discoveries and Interpreting Vascular Dementia Research for Better Health”

The conference proceedings were carried out through various Scientific-sessions, Plenary lectures, Workshop and Symposia of which the following topics were highlighted as Keynote-presentations:

Sleep apnea is a risk factor for cognitive decline of vascular origin- Antonio Culebras, Suny Upstate Medical University, USA

Working with migrant communities: achieving culturally competency in Dementia care- Karan Jutlla, De Montfort University, Leicester, UK

Asymptomatic Carotid Stenosis, Arterial Hypertension and Cognitive Impairment: A longitudinal population-based epidemiological study- Petya Mineva, Trakia University, Bulgaria

Spring Break: A True Story of Hope and Determination- Steven Benvenisti, Partner at Davis, Saperstein & Salomon, USA

Early stage work with raising awareness about Vascular Dementia in the African-Caribbean community in the London- David Truswell, Culture Dementia, UK

Blood Biomarkers in Preclinical Alzheimer Disease- Howard J Federoff, University of California, USA

Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals- Panteleimon Giannakopoulos, University of Geneva School of Medicine, USA



Medication management of behaviors in Vascular/Mixed Dementia in long term care: Successful case studies- Susan Scanland, University of Scranton, USA

Conference Series LLC has taken the privilege of felicitating Vascular Dementia 2016 Conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

Conference Series LLC , on behalf of the conference sponsor appreciates all the participants who put their efforts for this event and sincerely wishes them success in future endeavours.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Vascular Dementia 2016 Conference.

We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series LLC “Journal of Alzheimer’s Disease & Parkinsonism” as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums.

We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Vascular Dementia 2016.

With the unique feedbacks from the conference, Conference Series LLC would like to announce the commencement of the 6th International Conference on Vascular Dementia during February 27th - March 01st, 2017 at Amsterdam, Netherlands

Let us meet again @ Vascular Dementia 2017



• Vascular dementia is the second-most-common type of dementia in the United States and Europe in the elderly, however it is the most common form in some parts of Asia. The incidence of the illness is 1.5% in Western countries and just about 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America.

• One study found that in the United States precisely, the prevalence of vascular dementia in all individuals over the time of life of 71 is 2.43%, and another set up that the prevalence of the dementias doubles with every 5.1 years of age.

• The overall multi infarct dementia market is segmented into North America, Asia Pacific, Europe, Latin America and MEA. As of 2014, North America held largest market share in terms of revenue owing to the increasing incidences of multi infarct dementia coupled with increasing geriatric population base.

• Japan owing to increased geriatric base represents approximately more than 50% of the dementia cases in Asia Pacific.

• Various companies in the multi infarct dementia market are adopting several economical strategies such as collaborations, expansions and acquisitions to keep a strong position and gain advantage in the market.

• Alzheimer’s Research UK currently funds 150 research projects across the UK and has committed nearly £40million to dementia research.

• Their research will focus on improving the quality of life of those already living with Alzheimer’s disease and other forms of dementia.

• The Alzheimer’s Association funds independent investigators worldwide, they have awarded over $335 million to more than 2,250 projects.

• Research conducted by the Alzheimer’s Society, shows that there will be 850,000 people living with dementia in the UK by 2015. This will cost the UK £26 billion a year.

• Two-thirds (£17.4 billion) of the cost of dementia is paid by people with dementia and their families, either in unpaid care (£11.6 billion) or in paying for private social care.

Vascular Dementia Market Analysis



Conference HighlightsTrack 1 Dementia

Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Memory loss is an example. Alzheimer’s is the most common type of dementia.Track 2 Causes and Prevention

Dementia is caused by damage to brain cells. This damage interferes with the ability of brain cells to communicate with each other. When brain cells cannot communicate normally, thinking, behavior and feelings can be affected.Track 3 Vascular Dementia

Vascular dementia is defined as inadequate blood flow can damage and eventually kill cells anywhere in the body. In vascular dementia, changes in thinking skills sometimes occur suddenly following strokes that block major brain blood vessels. Vascular brain changes often coexist with changes linked to other types of dementia, including Alzheimer’s disease and dementia with Lewy bodies. Vascular dementia symptoms may be most obvious when they happen soon after a major stroke includes confusion, disorientation, trouble speaking or understanding speech and vision lossTrack 4 Ageing and Dementia

Almost 40 per cent of people over the age of 65 experience some form of memory loss. When there is no underlying medical condition causing this memory loss, it is known as “age-associated memory impairment,” which is considered a part of the normal aging processTrack 5 Advances in Dementia Test

A range of tests and diagnostic procedures is needed to diagnose dementia, but there are several that are fairly commonly used to diagnose dementia. These tests for dementia are mainly tests of mental abilities, blood tests and brain scans. Tests can help the doctor learn whether dementia is caused by a treatable condition. Even for those dementias that cannot be reversed, knowing the type of dementia a person has can help the doctor prescribe medicines or other treatments that may improve mood and behavior and help the family.Track 6 Dementia Stages

Progressive dementia, which is dementia that gets worse with time, is the most common type. Five stages of progressive dementia have been outlined. They are part of the Clinical Dementia Rating (CDR), which professionals use to evaluate the progression of symptoms in patients with dementia. The five stages describe a patient’s ability to perform in six different areas of cognition and functioning: orientation, memory, judgment, home and hobbies, personal care, and community. The stages include early dementia, Moderate dementia, Advanced dementia, Test of dementia stages, Advances in research of dementia stages.



Track 7 Dementia Care ManagementAlzheimer’s disease and other types of dementia can be a challenging journey, not only for the person

diagnosed but also for their family members and loved ones. Caring for someone with Alzheimer’s or dementia can seem overwhelming at times, but the more information and support you have, the better you can navigate the demanding road ahead and determine the long-term care options that are best suited to you and your loved one. There are some Alzheimer’s care preparations that are best done sooner rather than later. It may be hard to consider these questions at first, as it means thinking about a time when your loved one is already well down the road of his or her Alzheimer’s journey.Track 8 Vascular Dementia Nursing

Nursing is the protection, promotion, and optimization of health and abilities, prevention of illness and injury, facilitation of healing, alleviation of suffering through the diagnosis and treatment of human response, and advocacy in the care of individuals, families, groups, communities, and populations.Track 9 Advanced Drug for Dementia

The mainstay of management of vascular dementia is the prevention of new strokes. This includes administering antiplatelet drugs and controlling major vascular risk factors. Neuroprotective drugs such as nimodipine, propentofylline, and posatirelin are currently under study and may be useful for vascular dementia. Omentum in the treatment of vascular dementia. The sub tracks includes Cholinisterase inhibitors, Impact of treatment with N-Acetylcysteine, Oral redox polymer therapeutics, Snoezellen and Multi sensory stimulation, Effect of thioctic and enantiomers, Role of phospholipids, Effects of brain afobazole.Track 10 Potential Future Interventions

National Plan to Address Alzheimer’s Disease, a national effort to expand research in Alzheimer’s and related dementias prevention and treatment and to move the most promising drugs from discovery into clinical trials.

The Plan aims to prevent and effectively treat Alzheimer’s and related dementias by 2025. Its foundation is the 2011 National Alzheimer’s Project Act (NAPA), which was developed to create and maintain a national strategy to overcome the disease.Track 11 Neuro-entrepreneurship: Vascular Dementia

Brain is an intangible conundrum which buries millions and millions of memories.Entrepreneurship is the process of designing a new bu

Track 12 Animal Models and Translational MedicineAnimal models for Alzheimer’s disease it is important to think about the human phenotype and what is

being modeled in terms of the animal phenotype. The moderator, Bradley Hyman, professor of neurology at Harvard Medical School, said that animal models of Alzheimer’s disease, based on the genetics of the disease and the closely related front temporal dementia, replicate at least some of the pathology. Researchers have been successful at modeling very specific aspects of Alzheimer’s disease in the mouse (e.g., plaques, tangles). Although these are incomplete models of the human disease, they have been well received in the field as potentially relevant models for use in drug discovery.



Expertise Outlook on Neuroscience Conferences

Arvid Carlsson, Nobel Prize in Physiology/ Medicine for 2000I wish to welcome all researchers from the fields of basic neuroscience, neurology, and neurosurgery to contribute with your valuable expertise, and to stimulate interdisciplinary endeavor.

John K. Grandy, North Country Urgent Care, USA I had a great time at the conference this year and it was run much more efficiently than last year in Chicago. Thank you for the opportunity to participate

Eric G. Tangalos, Mayo Clinic Alzheimer’s Disease Center, USAYour opportunities will include not only excellent science, but provide practical applications of knowledge to advance the care of your patient with cognitive, behavioral and functional decline.

Krikor Dikranian, Washington University, USA I would like to thank the OMICS group and you for giving me the opportunity to participate in the meeting. I met with some wonderful people, the atmosphere was delightful. I look forward to be able to participate again

Maria Elisa, Hospital of the Rio de Janeiro, BrazilWe have beautiful two days in San Antonio Conference, Congratulations to organized committee.

Andrew V Schally, Nobel Prize in Physiology/Medicine for 1977Conferences like this one may help to speed up the development of effective therapies for neurodegenerative diseases like Alzheimer’s disease.

Marie Trad, Quintiles, France The meeting was very interesting and I met with very nice people

Mitchell Clionsky, Clionsky Neuro Systems, USA We believe that the conference proved to be a stimulating blend of many disciplines and that it created numerous opportunities for participants to broaden their awareness

Jose Leon-Carrion, University of Seville, SpainWe encourage you to participate in this event with original free papers and high-quality presentations on all aspects of dementia. We sincerely hope we can count on your contribution to this international platform and join us in working towards the generation of more effective therapies at all stages of this disease.

Jennifer DeFeo, The Chicago school of professional psychology, USAI really enjoyed this conference

Boris Johnson, Mayor of London, UKAs Mayor of London I am delighted to welcome you to the Neurology Conferences organized by OMICS International




Wayne Carter, University of Nottingham, UKWe had an excellent day of talks thank you, lots of interest and questions for each of the talks.

Kathy Sexton Radek, Suburban Pulmonary & Sleep Associates, USAThe presentations varied from Basic Science in the physiological correlated Sleep Disorders to practice applications involving diagnostic, assessment and treatment of Sleep Disorders. Scientists and Practitioner from around the world attended our conference

Hans Von Holst, Royal Institute of Technology, SwedenThank you for a well-organized Brain Disorders Conference

Sha Mi, Biogen, USAThe meeting went well and lot of questions today! I will attend the OMICS meeting again!

Heinz Reichmann, University of Dresden, GermanyThis conferences is really timely and informed about symptoms, diagnosis and modern treatment of neuro patients

Emily Clionsky, Clionsky Neuro Systems, USABased on what we saw and with whom we spoke, we are sure that you enjoyed a productive and worthwhile experience. We ask that you share your experience with your colleagues, as well as urge them to support these meetings.

Alon Y. Avidan, California Sleep Society, USASleep Medicine 2015 illuminated the gravity of the topic, how it affects our day to day lives, prevention and stairway to a healthier tomorrow

Norman S. Miller, Michigan State University, USAThe priority aim of this Conferences will also be to deepen our understanding around the interrelationship of addictive disorders between each other, as well as with mental health, Addiction Psychiatry, family, community, and culture.

Wayne Carter, University of Nottingham, UKThe feedback from the participants was really positive - we all thought the meeting was a great success. Relatively small meetings such as this one enabled us to get to know each other better and discuss overlapping interests and future collaborations.

Howard Prentice, Florida Atlantic University, USAWe take great pleasure in welcoming you to our Neurology Conferences and understand that this will be an excellent opportunity for disseminating new research findings as well as enabling investigators to explore innovative and emerging aspects of this critically important research field

Michiaki Nagai, Jichi Medical University, JapanIt was very grateful that I could participate the congress, I was very impressed because the contents of the discussion were very high quality, and I enjoyed the interesting talk with many investigators, So, I think that the conference was very high level and well organized.




Ayman Alboudi, UAEIt was a great pleasure to be there. Hope we meet soon

Odeda Peled, Integrative Therapy Center, IsraelThe convention itself was very nice, dignified and well organized

Oleksandr Makarenko, Taras Shevchenko National University of Kyiv, Ukraine I want to write, that the organization of the Conference was almost on high level

Jacqueline Sidman, The Sidman Institute, USAIt was my pleasure to participate. I enjoyed it very much

Nagwa Abdel Meguid, National Research Centre, EgyptIt was really wonderful conference

Joao Maria Nabais, PortugalI must confirm to you, my grateful pleasure being part and has participated in this important International Conference

Suhera Abrewal, University of Tripoli, LibyaIt’s been my pleasure to participate in this event, and beneficial by sharing interests with attendees and new connections.

Pablo Bellido Correa, University of Valencia, SpainWe wanted to thank all the work this committee has made for us and for the Best Poster Presentation. We have received recognition in Spain, both at our University and at local and National media. Much of our activity is tracked by media and news

Guang-Xian Zhang, Thomas Jefferson University, USA Congratulations for your excellent organizing!

Susan Henning, DeVry University, USAAbsolutely good quality Programs, Thank you

Shireen Qureshi, Saudi Stroke Association, DubaiIt is my pleasure to welcome you to this important event with great honor and respect, we are delighted to invite you to be part of our International meet.



Vascular Dementia 2017 aims to fasten the advancement of scientific knowledge that may ultimately result in a better prognosis for patients. International conference is the best platform to develop new partnership & collaborations .It provides an important base for the exchange of knowledge and experience amongst the clinicians. The internationally renowned speakers at this conference will explore the various aspects of Vascular Dementia.

Vascular Dementia 2017• Opportunity to attend the presentations delivered by eminent scientists from all over the world• Selected contributions will be published in following Conference Series LLC Journals

• Journal of Alzheimers Disease & Parkinsonism

• Journal of Neurological Disorders

• Brain Disorders & Therapy

• Participation in sessions on specific topics on which the conference is expected to achieve progress • Global networking: In transferring and exchanging Ideas• Share your excitement in promoting Health care, Clinical R & D

• Conference brings together Scientific Researchers, Business Entrepreneurs and Pharma, Healthcare, Industry Developers

Supporting Journals



Amsterdam is the capital city and most populous city of the Kingdom of the Netherlands.

Its status as the Dutch capital is mandated by the Constitution though it is not the seat of the Dutch government, which is The Hague. As is the case in all the countries with the highest health care expenditures, the Netherlands has an exceptionally strong economy.

The country’s GDP per capita was estimated at $41,711 in 2013, higher than all but a handful of OECD nations. The Dutch government paid the vast majority of health care costs, with nearly 86% of all spending coming from public sources in 2012, the highest proportion in the OECD.

Netherlands government allocate EUR 32.5 million to the fight against Neurological disease over the next four years. The Netherlands Organisation for Scientific Research (NWO) provided fund of €550 million to fuel the research on mental illness. NARSAD Young Investigator Grant provides $30,000 per year on research in Neural and behavior disorders such as schizophrenia, mood disorders, anxiety disorders, or child and adolescent mental illnesses.

Amsterdam is currently one of the best European cities in which to locate an international business. It is ranked fifth in this category and is only surpassed by London, Paris, Frankfurt and Barcelona. Many large corporations and banks have their headquarters in Amsterdam, including Akzo Nobel, Heineken International, ING Group, ABNAMRO, TomTom, Delta Lloyd Group and Philips. KPMG International’s global headquarters is located in nearby Amstelveen, where many non-Dutch companies have settled as well, because surrounding communities allow full land ownership, contrary to Amsterdam’s land-lease system.

About Amsterdam



Important DatesAbstract submission opens: August 01, 2016Registration opens: August 01, 2016Early bird registration: December 01, 2016On spot registration: February 27, 2017

Registration BenefitsContribute to and learn about the most recent advances in vascular dementia fieldAccepted abstract will be published in respective OMICS journalsEach abstract will receive a Digital Object Identifier (DOI) provided by crossrefConference will contribute to increment in overall research profileGolden chance to meet other researchers in neurology field and potential contacts for futurepositionsInternational platform for presentation skills and expertise to discuss the research in clearand meaningful way

VenueAmsterdam, Netherlands

Registration DetailsRegister onlinehttp://vasculardementia.conferenceseries.com/registration.php

Important Links



Conference Series LLC Journals • 500 Open Access Journals• 21 Day rapid review process• 30000 Editorial team, 35000 Reviewers team• 3.5 Million readers and high visibility• More than 100000 • Publication immediately after acceptance• Quality and quick editorial, review processing

Key features • User friendly/feasible website translation of your paper to 50

world’s leading languages • Enhanced feature: Audio version of published paper• Digital articles to share and explore• Sharing option: Social networking enabled• Authors, reviewers and editors are provided with scientific

credits

Conference Series LLC Conferences • 300 Conferences all over the World every year• Well organized scientific program • Renowned speakers and scientists across the globe• Poster presentations and world class exhibits• Panel discussions and interactive sessions• B2B meetings• Perfect platform for Global Networking

Key features • Presentation by renowned speakers from all over the world• Poster presentations and world class exhibits• Interactive Sessions• Platform for global networking• Connecting scientific community

Special Issues All accepted abstracts will be published in respective Conference Series LLC Journals

Each abstract will be provided with digital Object Identifier by

About Us

Date post:	14-Feb-2017
Category:	Documents
Upload:	priya-gupta
View:	171 times
Download:	0 times

Vascular Dementia 2017_Brochure

Documents